RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Premium Company Profile: Neurocrine Biosciences Inc
Nov 2007 - 53 pages - $495
Cougar Biotechnology Inc: Premium Company Profile
Apr 2008 - 39 pages - $495
Tercica Inc: Premium Company Profile
Dec 2007 - 56 pages - $495
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
MarketWatch: Biotechnology
Dec 2008 - 35 pages - $200
Company Financials: Neurocrine Biosciences, Inc.
Jan 2010 - $75
Drug Delivery Markets, Vol. IV: Transdermal and Trans Mucosal Drug Delivery
Apr 2007 - 118 pages - $2,495
Neuro Endocrine Carcinoma - Pipeline Review, Q2 2011
Apr 2011 - 100 pages - $500
Theratechnologies Inc: Premium Company Profile
Apr 2008 - 45 pages - $495
Sanofi-Aventis Acquires Genzyme Corporation for $20 billion - Deal Analysis from GlobalData
May 2011 - 5 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Endocrinology del
Endocrine system del
Year
2002 del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Manufacturing
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us